Clinical Trial Update: A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)

View source ↗

Summary

This clinical trial update indicates that the second intermediate-size Expanded Access Protocol for pridopidine in people with amyotrophic lateral sclerosis is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Pridopidine (pridopidine)

Snippet

Sponsor: Prilenia | Conditions: Amyotrophic Lateral Sclerosis | Status: NO_LONGER_AVAILABLE